News

Opening of Biotech Training Facility Leiden with Minister Kamp

8 February 2016 Minister Kamp at the opening the Biotech Training Facility Leiden.

ERA HDHL Cofunded Call Biomarkers in Nutrition and Health

3 February 2016 The JPI HDHL -together with the European Commission - is going to launch a new joint transnational call for research proposals: "Biomarkers for Nutrition and Health (BioNH)“ using the ERA-NET Cofund instrument.

Health~Holland Year in Review 2015

2 February 2016 We are pleased to publish the Health~Holland Year in Review 2015, our yearly magazine that brings you the developments from Top Sector Life Sciences & Health in 2015.

Top Team member Hans Schikan wins Roland Lageveen Award

29 January 2016 Tweejaarlijkse Award voor een persoon of organisatie die een uitzonderlijke bijdrage leverde aan het succes van de Nederlandse biotech sector.

Polyganics Receives 510,000 euros Clearance for Nerve Capping Device

29 January 2016 Polyganics, a privately held medical technology company focused on the commercialization of proprietary products and technologies for peripheral nerve repair, neurosurgery, general surgery, as well as ear, nose & throat surgery, announced it has received FDA 510,000 euros clearance for NEUROCAP, an innovative device designed to reduce painful neuroma formation and thereby facilitate tissue repair and regeneration.

#1 Healthcare in Europe according to the EHCI Report

28 January 2016 The Dutch receive the best care in Europe states the Euro Health Consumer Index 2015 report, released beginning of 2016.

Mimetas and Partners Receive 1.6 Million Dollar Industry Funding for Development of Organ-On-A-Chip Neurotoxicity Models

22 December 2015 Leiden-based biotechnology company Mimetas has received 1.6 million USD funding for development of an organ-on-a-chip model for neurotoxicity. The aim of the project is to improve existing neurotoxicity tests and to reduce experimentation on animals.

Agendia and Partners Receive $6.8 million from European Commission to Study Targeted Therapies for Colorectal Cancer

18 December 2015 Agendia, Inc. and several European partners have received a $6.8 million European Commission grant to study targeted therapies for colorectal cancer (CRC). The grantees will test therapies matched to the molecular subtype of each patient’s tumor, to see if they are more effective than current therapies not keyed to a tumor’s subtype.

AstraZeneca enhances long-term growth through Oncology investment in Acerta Pharma

17 December 2015 Acerta Pharma has entered into a definitive agreement with AstraZeneca whereby AstraZeneca will acquire a majority stake in Acerta.

Collaboration Top Sectors results in 1.4 million for research projects on autonomy in dementia

17 December 2015 Samenwerking Topsectoren Creatieve Industrie en Life Sciences & Health levert 1,4 miljoen op voor onderzoek naar zelfstandigheid bij dementie. Twee grootschalige projecten met de namen FIT en Roodkapje maken aanspraak op de subsidie.